Nighttime Synchrony of Your Nutrition and Circadian Health

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorUniversity of Utah

About this trial

Sleep is an important factor for overall health. This study will see how different light exposure patterns and food intake impact a person's metabolism (how the body breaks down food) when sleeping is reduced.

Participants will attend 6 to 8 in-person visits to the study clinic, including three overnight stays. People will complete surveys and medical tests. The study will last about 4 to 6 months.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age: 18-35 years old; equal numbers of men and women

Body Mass Index (BMI): 18.5-24.9 kg/m2

Sleep Habits: habitual self-reported average total sleep time (TST) 7-9 hours per night for prior 6 months

Disqualifiers

Clinically diagnosed sleep disorder or apnea hypopnea index (AHI) ≥5

Evidence of significant organ system dysfunction or disease (e.g., heart disease, diabetes)

Fasting plasma glucose ≥100 mg/dL

Major psychiatric illness (e.g., major depressive disorder)

Trial design

Design model

Crossover

Treatments tested in this trial

  • Central Clock Misalignment

    Behavioral

    Light exposure will be dimmed during the first 4 hours of scheduled wakefulness, with bright light exposure during the nighttime hours of extended wakefulness.

  • Peripheral Misalignment

    Behavioral

    Most daily calories will be given later in the day to shift eating patterns toward the nighttime hours.

Treatment groups

120 Participants
are divided into 3 treatment groups
Group A: Sleep Restriction with Central and Peripheral AlignmentNo intervention 0 interventions
Group B: Sleep Restriction with Central Clock MisalignmentExperimental treatment 1 intervention
Group C: Sleep Restriction with Peripheral MisalignmentExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Insulin Sensitivity

Insulin sensitivity will be measured by intravenous glucose tolerance tests.

Time frame
Immediately following the 5-day sleep restriction segment
2

Internal Circadian Misalignment (Uridine and Isobutyryl-L-carnitine)

Phase angle between DLMO and acrophase of uridine and isobutyryl-L-carnitine during constant routine.

Time frame
During the constant routine, following the 5-day sleep restriction segment

Secondary outcomes

Other outcomes

1

Timing of DLMO and DLMOff

The phase angle between dim-light melatonin offset (DLMOff) scheduled waketime using hourly saliva samples collected during a constant routine.

Time frame
During the constant routine, following the 5-day sleep restriction segment
2

Hunger and Satiety Visual Analog Scales

Self-reported ratings of hunger, satiety, and prospective food intake will be quantified by 100mm visual analog scales ranging from 0 to 100. For each scale, 0 represents low hunger, satiety, or prospective food intake, with 100 representing the highest hunger, satiety, or prospective food intake.

Time frame
During the constant routine, following the 5-day sleep restriction segment

Sponsors and contacts

Click on the lead sponsor to view all of their trials.